Drug Store News - Schering-Plough files Clarinex NDA
Sunday, December 28th, 2008Schering-Plough, maker of the blockbuster antihistamine Claritin (loratadine) has filed a new drug application with the Food and Drug Administration to broaden the indication of its new drug Clarinex 5mg (desloratadine). Schering says Clarinex, positioned as a successor to the manufacturer’s blockbuster Claritin, currently t…
